Pharma Enhances Patient Recruitment Methods Through Industry Site Level Dataset

Main Category: Pharma Industry / Biotech Industry
Article Date: 17 Jun 2009 - 3:00 PDT

Current ratings for:
'Pharma Enhances Patient Recruitment Methods Through Industry Site Level Dataset'

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:4 stars

4 (4 votes)


KMR GROUP, a firm analyzing biopharmaceutical R&D performance since the early 1990s, announces SiteView, its newest module in the Enrollment Metrix Application. Enrollment Metrix helps companies plan more effectively and reliably when setting recruitment targets and timelines, therefore helping companies save millions of dollars due to delay and non-conformance.

SiteView users can examine enrollment KPIs derived from site level data. The information is used for planning and forecasting recruitment in clinical trials. This new module allows users to anticipate the expected number of patients to be recruited from any given site as well as the time it takes any given site to complete recruitment. Thus, the data gives companies a more nuanced view when it comes to planning for any region or country.

The TrialView module, used by a variety of companies since its unveiling in 2005, enables planning and performance measurement at a broader level. The module enables companies to plan study start up and recruitment time as well as volume of patients and sites for a given trial at a global, region or country level.

One key benefit of Enrollment Metrix (SiteView and TrialView) is its unparalleled access to industry data. No company on its own can have the same statistically-valid sample sizes once it starts to segment the data into finer parcels such as disease, phase, or geography. KMR Group has the broadest repository of enrollment industry information available, all obtained directly from the world's major biopharmaceutical companies. With access to data from close to 100,000 sites from thousands of recently-completed trials, users can have confidence in the quality and breadth of data.

Use Enrollment Metrix to develop more innovative enrollment and site-based strategies, assess enrollment performance, plan more effectively, evaluate opportunities in emerging markets, and identify ways to reduce cost. The tool is flexible; results can be depicted in a variety of ways, including in maps, grids, box & whisker charts, and tables. All charts and tables can be easily saved by the user and employed for internal discussion or presentation.

"We are providing biopharmaceutical companies with a solution to address their most important recruitment questions. The need for reliable data, flexible criteria and robust viewing options is now satisfied with our enhanced Enrollment Metrix Application," commented Linda Martin, Principal of KMR GROUP.

Source
KMR

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
KMR GROUP. "Pharma Enhances Patient Recruitment Methods Through Industry Site Level Dataset." Medical News Today. MediLexicon, Intl., 17 Jun. 2009. Web.
24 May. 2012. <http://www.medicalnewstoday.com/releases/154189.php>

APA
KMR GROUP. (2009, June 17). "Pharma Enhances Patient Recruitment Methods Through Industry Site Level Dataset." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/154189.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Pharma Enhances Patient Recruitment Methods Through Industry Site Level Dataset'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »